BLRX falling wedge: pending breakoutFollowing my previous idea on NASDAQ:BLRX we're now forming a wedge with a local bullish divergence. First target would be range high around $0.19. If we break it and retest that level, we can aim for a (partial) gap fill and a local bullish trend. First we need a break from the wedge.
To be con
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.48 USD
−9.22 M USD
28.94 M USD
3.70 M
About BIOLINE RX
Sector
Industry
CEO
Philip Adam Serlin
Website
Headquarters
Modi'in
Founded
2003
FIGI
BBG001Y26LK0
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Mean reversion for BLRXBLRX dumped over 40% yesterday on dilution news, an overreaction from the market imo. Bought the bottom around $0.15 which is way undervalued for what the company has in the pipeline. Company is now cash healthy for a while with $10 million for research. It's trading at $1,49 on the TASE - so heavy
BLRX Weekly Analysis: Falling Wedge + Monthly Bullish DivergenceAnalyzing BLRX on the weekly timeframe, the stock is showing a classic falling wedge pattern, a bullish reversal formation.
• Key Support: Holding strong at the $.40 level.
• Target: $1.00 +, Near strong resistance level.
SL: $.35 & $.31
Why This Chart is Interesting:
1. Bullish Divergence: M
$BLRX is gonna fall todayPupm&Dump trading strategy idea.
$BLRX is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $3,66;
stop-loss — $3,82;
take-profit — $3,36.
Do not view th
real sleeperI honestly believe this stock is a real sleeper. analysts predict a 247% increase from current levels. I would keep an eye on this one. Tight squeeze showing as it continues to consolidate. reminder, this stock has been consolidating for a while now and the longer the consolidation the bigger the pu
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.